Stock Performance and Market Context
The stock of Yatharth Hospital & Trauma Care Services Ltd, operating within the hospital sector, demonstrated robust gains on 26 August 2026, closing at ₹943.50. This price surpasses its previous 52-week high of ₹938.00 by approximately 0.59%, signalling a fresh peak in its valuation. The day’s performance saw a gain of 2.23%, significantly outperforming the Sensex, which rose by 0.33% on the same day.
Over the past week, the stock has surged by 10.56%, compared to the Sensex’s modest 1.30% increase. The one-month return stands at 12.60%, while the three-month performance is even more impressive at 15.71%, both substantially outpacing the broader market indices. Year-to-date, Yatharth Hospital has delivered a remarkable 38.43% return, contrasting with the Sensex’s decline of 8.58% over the same period.
Longer-term trends also highlight the company’s strong market presence, with a three-year return of 140.38%, vastly exceeding the Sensex’s 20.07% gain. These figures underscore the stock’s consistent upward trajectory and resilience within the hospital sector.
Technical Indicators and Trend Analysis
The technical outlook for Yatharth Hospital & Trauma Care Services Ltd remains bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, reinforcing the strength of its current uptrend. The overall technical trend shifted to bullish on 25 August 2026 at a price level of ₹922.90, marking a clear directional change from a mildly bullish stance.
Key technical indicators present a mixed but predominantly positive picture. Weekly MACD and Bollinger Bands signal bullish momentum, while monthly Bollinger Bands and Dow Theory also support the upward trend. Although some indicators such as the KST and OBV show mild bearish or mixed signals, the dominant trend remains positive. Immediate support is identified at the 52-week low of ₹538.15, with resistance levels at ₹858.44 (20 DMA), ₹820.18 (100 DMA), and ₹750.90 (200 DMA), all of which have been decisively surpassed by the current price.
Valuation Metrics and Financial Ratios
At the current price of ₹943.50, Yatharth Hospital & Trauma Care Services Ltd trades at a price-to-earnings (P/E) ratio of 49x on a trailing twelve months (TTM) basis. The price-to-book value (P/BV) stands at 5.00x, while the enterprise value to EBITDA (EV/EBITDA) ratio is 28.71x. Other valuation multiples include an EV/EBIT of 42.59x and EV/Sales of 6.68x, reflecting the premium investors place on the company’s earnings and sales growth.
The PEG ratio is recorded at 1.79x, indicating a valuation that factors in the company’s earnings growth rate. Dividend yield remains modest at 0.05%, with the latest dividend declared at ₹0.493 per share and an ex-dividend date of 14 August 2026.
Quality Assessment and Financial Health
Yatharth Hospital & Trauma Care Services Ltd is classified as an average quality company based on its long-term financial performance. The company exhibits strong capital structure with negligible debt, reflected in an average debt to EBITDA ratio of 0.35 and net debt to equity close to zero. Interest coverage is robust at 20.46 times, underscoring the company’s ability to comfortably service its debt obligations.
Growth metrics are encouraging, with a five-year sales compound annual growth rate (CAGR) of 33.26% and EBIT growth of 19.96%. Return on capital employed (ROCE) averages a healthy 17.68%, although return on equity (ROE) is relatively weak at 9.01%. Management risk is assessed as below average, while capital structure is rated excellent, contributing to the overall stable financial profile.
Recent Financial Trends
The short-term financial trend as of June 2026 is positive. The company reported a profit after tax (PAT) of ₹139.93 crores for the nine-month period, reflecting a growth rate of 25.78%. Quarterly net sales reached a high of ₹392.65 crores, accompanied by a peak PBDIT of ₹91.68 crores and a PBT (excluding other income) of ₹56.86 crores. The debtors turnover ratio for the half-year period stands at 3.20 times, indicating efficient receivables management.
No significant negative financial triggers have been identified in recent reports, supporting the company’s upward momentum and reinforcing investor confidence in its financial stability.
Trading Volumes and Market Capitalisation
Trading activity has intensified, with delivery volumes showing a 1-day increase of 122.31% compared to the five-day average. The trailing one-month delivery volume rose by 18.43%, reflecting heightened investor participation. The stock is classified as a small-cap entity, with a market cap grade consistent with its size and sector positioning.
Consecutive gains over the last four trading days have resulted in an 8.73% return during this period, further highlighting the stock’s strong performance and positive market sentiment.
Summary of Market Momentum
Yatharth Hospital & Trauma Care Services Ltd’s ascent to an all-time high price of ₹943.50 on 26 August 2026 marks a significant milestone in its market journey. The stock’s consistent outperformance relative to the Sensex and its sector peers, combined with strong technical indicators and solid financial metrics, illustrate a well-supported valuation peak.
The company’s average quality rating, strong capital structure, and positive short-term financial trends contribute to the sustainability of this performance. While valuation multiples suggest a premium, they are reflective of the company’s growth trajectory and market positioning within the hospital sector.
Overall, the achievement of this all-time high price underscores Yatharth Hospital & Trauma Care Services Ltd’s continued strength and resilience in a competitive market environment.
